Loading in 2 Seconds...
Loading in 2 Seconds...
Preparing for and Responding to Bioterrorism: Information for the Public Health Workforce. Acknowledgements. This presentation, and the accompanying instructor’s manual, were prepared by Jennifer Brennan Braden, MD, MPH, at the
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
This presentation, and the accompanying instructor’s manual,
were prepared by Jennifer Brennan Braden, MD, MPH, at the
Northwest Center for Public Health Practice in Seattle, WA, for the
purpose of educating public health employees in the general aspects of
bioterrorism preparedness and response. Instructors are encouraged
to freely use all or portions of the material for its intended purpose.
The following people and organizations provided information and/or
support in the development of this curriculum. A complete list of
resources can be found in the accompanying instructor’s guide.
Patrick O’Carroll, MD, MPH
Centers for Disease Control and Prevention
Design and Editing
Health Policy and Analysis; University of WA
Washington State Department of Health
Jeff Duchin, MD
Jane Koehler, DVM, MPH
Communicable Disease Control,
Epidemiology and Immunization Section
Public Health - Seattle and King County
Ed Walker, MD; University of WA
Department of Psychiatry
*initial confirmation of outbreak requires testing in level D lab (I.e., CDC)
Lesions most abundant on
face and extremities,
More on CDC's response plan...
ACIP, June 2002
Vaccine admin instructions
Sourced: MMWR June 22, 2001 / 50(RR10);1-25. Vaccinia (Smallpox) Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001
*Vaccines 3rd Ed. Plotkin SA, Orenstein WA. W.B. Saunders, Phila. 1999
Most cases occur in children
Expected case fatality rate 2-3/100,000
Secondary attack rate of 80% among susceptible household contacts
Most of the population expected to be susceptible
Expected case fatality rate averages 30%
Secondary attack rate ~60% in unvaccinated family contactsDistinguishing Smallpox from Chickenpox: Epi Featuresthat Differ
Rash concentrated on trunk
Lesions rarely on palms or soles
Lesions in different stages of development
Rash progresses more quickly
Rash concentrated on face & extremities
Lesions on palms & soles
Lesions in same stage of evolution on any one area of body
Rash progresses slowlyDistinguishing Smallpox from Chickenpox: Clinical Featuresthat Differ